Medicine News and Research

RSS

Keryx Biopharmaceuticals reaches SPA agreement for Phase 3 clinical program for Zerenex

Keryx Biopharmaceuticals, Inc. announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 clinical program for Zerenex(TM) (ferric citrate), its iron-based phosphate binder for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD).

6 Jan 2010

UC San Diego bioengineering professor receives 2009 Presidential Science Prize

For Shu Chien - a pioneer in the growing field of bioengineering - understanding and learning the marvels of how the human body works has been the foundation of his decades-long quest to advance science and technology worldwide. The UC San Diego bioengineering professor's significant scientific endeavors have paved the way for recognition of his renowned work at the university's Jacobs School of Engineering and abroad.

6 Jan 2010

ATP-sensitive potassium channel can contribute to fat deposition and obesity, new study says

A new study involving the University of Iowa, Mayo Clinic and two other institutions provides insight on weight control, suggesting that a ATP-sensitive potassium channel critical to survival and stress adaptation can contribute to fat deposition and obesity.

6 Jan 2010

'Make Today the Day' public awareness campaign to quit smoking launched

At a time when many smokers consider quitting for the New Year, today is a timely launch of a partnership that joins together mutual public health interests sought by the American Lung Association in California, Healthy San Francisco and the city's Public Health Office in a citywide public awareness campaign aimed to help smokers achieve that goal.

6 Jan 2010

Animal experiments show old antidepressant may reverse heart failure

A team of Johns Hopkins and other researchers have found in animal experiments that an antidepressant developed over 40 years ago can blunt and even reverse the muscle enlargement and weakened pumping function associated with heart failure.

6 Jan 2010

Excaliard Pharmaceuticals initiates Phase 2 trials of EXC 001

Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.

6 Jan 2010

Biomet reports second quarter financial results for fiscal 2010

Biomet, Inc. net sales increased 8% during the second fiscal quarter ended November 30, 2009, to $695.6 million from $642.8 million during the second quarter of fiscal year 2009. On a constant currency basis, net sales increased 5% during the second quarter of fiscal 2010.

6 Jan 2010

Multidisciplinary care, patient decision aids rarely offered by breast cancer surgeons

Most breast cancer surgeons' practices do not follow standards associated with the best quality of care, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

6 Jan 2010

Rural Americans often struggle to access care

Access to care remains a major burden for Americans in rural areas, according to recent media reports. The Texas Tribune reports: "Across much of rural Texas, emergency or trauma care is simply nonexistent, or limited to one ambulance and a part-time EMS crew. ... Roughly half of the state is covered by the trauma centers in El Paso and Lubbock. In remote counties in West Texas, South Texas and the Panhandle, residents are often more than an hour from any trauma care at all."

6 Jan 2010

Link Resources announces completion of share exchange transaction and private placement

Link Resources, Inc. announced today the completion of a share exchange transaction and concurrent US$12 million private placement pursuant to which it acquired the parent company of Yantai Bohai Pharmaceuticals Group Co., Ltd. (“Bohai”).

6 Jan 2010

AMICAS announces new contract with Asheville Radiology Associates

AMICAS, Inc., a leader in image and information management solutions, today announced a new contract with Asheville Radiology Associates (Asheville, NC). This agreement will allow Asheville Radiology to use AMICAS Financials(TM) for radiology billing, AMICAS Dashboards(TM) for business intelligence, and AMICAS Patient Services((SM)) and AMICAS Payer Services((SM)) for streamlining their radiology billing processes.

6 Jan 2010

Vitamin D deficiency may contribute to higher risk of death among African-Americans compared to whites

Vitamin D deficiency may contribute to a higher number of heart and stroke-related deaths among black Americans compared to whites, according to a University of Rochester Medical Center study.

6 Jan 2010

Genetic rogue elements could help diagnose breast and bowel cancer

Scientists at The University of Nottingham have found that a group of genetic rogue elements, produced by DNA sequences commonly known as 'junk DNA', could help diagnose breast and bowel cancer.

5 Jan 2010

WPI researchers lay groundwork for new generation of advanced prosthetic limbs

The conflicts in Iraq and Afghanistan have left a terrible legacy: more than 1,200 returning American soldiers have lost one or more limbs. To address this growing national need, researchers at Worcester Polytechnic Institute (WPI) are laying the groundwork for a new generation of advanced prosthetic limbs that will be fully integrated with the body and nervous system.

5 Jan 2010

Northwest Hospital & Medical Center collaborates with UW Medicine Health System to improve healthcare

Following final regulatory review, Northwest Hospital & Medical Center, a 281-bed full-service acute care hospital, has joined the UW Medicine Health System, effective January 1.

5 Jan 2010

PanGenex adds number of CAM practitioners to national physicians' referral network

PanGenex Corporation, a global nutraceutical and dietary supplement manufacturer and marketer, announced today it has added a number of complementary alternative medicine (CAM)/holistic medical practitioners to its national physicians' referral network.

5 Jan 2010

Phase 2 study evaluating VBL Therapeutics' lead compound VB-201 initiated

VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.

5 Jan 2010

Article provides issues and challenges encountered by hospitals in implementing cooling program for post arrest patients

The European Resuscitation Council (ERC) and Elsevier's journal Resuscitation chose a randomized controlled study demonstrating a trend toward faster cooling and better control with Medivance's Arctic Sun® Temperature Management System as its featured "Article of the Month."

5 Jan 2010

Woodcock discusses FDA's ongoing initiative to reduce preventable harm from medication use

An article by Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research, titled "A Difficult Balance - Pain Management, Drug Safety, and the FDA," appears in the Nov. 26, 2009 issue of The New England Journal of Medicine.

5 Jan 2010

U.S. Preventive Medicine's groundbreaking approach to prevention featured on "Hannity"

Christopher Fey, Chairman and CEO of U.S. Preventive Medicine®, today announced the company's groundbreaking approach to prevention was featured on "Hannity" on FOX News Channel.

5 Jan 2010

Medicine News and Research

Keryx Biopharmaceuticals reaches SPA agreement for Phase 3 clinical program for Zerenex

UC San Diego bioengineering professor receives 2009 Presidential Science Prize

ATP-sensitive potassium channel can contribute to fat deposition and obesity, new study says

'Make Today the Day' public awareness campaign to quit smoking launched

Animal experiments show old antidepressant may reverse heart failure

Excaliard Pharmaceuticals initiates Phase 2 trials of EXC 001

Biomet reports second quarter financial results for fiscal 2010

Multidisciplinary care, patient decision aids rarely offered by breast cancer surgeons

Rural Americans often struggle to access care

Link Resources announces completion of share exchange transaction and private placement

AMICAS announces new contract with Asheville Radiology Associates

Vitamin D deficiency may contribute to higher risk of death among African-Americans compared to whites

Genetic rogue elements could help diagnose breast and bowel cancer

WPI researchers lay groundwork for new generation of advanced prosthetic limbs

Northwest Hospital & Medical Center collaborates with UW Medicine Health System to improve healthcare

PanGenex adds number of CAM practitioners to national physicians' referral network

Phase 2 study evaluating VBL Therapeutics' lead compound VB-201 initiated

Article provides issues and challenges encountered by hospitals in implementing cooling program for post arrest patients

Woodcock discusses FDA's ongoing initiative to reduce preventable harm from medication use

U.S. Preventive Medicine's groundbreaking approach to prevention featured on "Hannity"

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News